Index S&P 500
P/E -
EPS (ttm) -10.01
Insider Own 17.88%
Shs Outstand 864.00M
Perf Week 21.38%
Market Cap 9.59B
Forward P/E 7.13
EPS next Y 1.46
Insider Trans 0.00%
Shs Float 710.05M
Perf Month 15.06%
Income -8636.00M
PEG -
EPS next Q 0.39
Inst Own 60.96%
Short Float 14.26%
Perf Quarter 15.19%
Sales 147.66B
P/S 0.06
EPS this Y -46.81%
Inst Trans 0.11%
Short Ratio 4.35
Perf Half Y -33.18%
Book/sh 12.09
P/B 0.86
EPS next Y -4.89%
ROA -9.72%
Short Interest 101.28M
Perf Year -57.82%
Cash/sh 3.37
P/C 3.09
EPS next 5Y -
ROE -56.69%
52W Range 8.08 - 27.05
Perf YTD -60.21%
Dividend Est. 1.20 (11.54% )
P/FCF -
EPS past 5Y -
ROI -21.41%
52W High -61.59%
Beta 0.63
Dividend TTM 1.00 (9.62% )
Quick Ratio 0.37
Sales past 5Y 1.77%
Gross Margin 16.30%
52W Low 28.59%
ATR (14) 0.61
Dividend Ex-Date Nov 18, 2024
Current Ratio 0.68
EPS Y/Y TTM -180.71%
Oper. Margin 1.20%
RSI (14) 63.50
Volatility 12.65% 6.36%
Employees 312000
Debt/Eq 3.24
Sales Y/Y TTM 6.17%
Profit Margin -5.85%
Recom 2.85
Target Price 9.94
Option/Short Yes / Yes
LT Debt/Eq 2.86
EPS Q/Q -1570.28%
Payout -
Rel Volume 1.66
Prev Close 9.73
Sales Surprise 5.02%
EPS Surprise 8.85%
Sales Q/Q 6.00%
Earnings Jan 09 BMO
Avg Volume 23.31M
Price 10.39
SMA20 15.81%
SMA50 12.20%
SMA200 -21.14%
Trades
Volume 38,608,803
Change 6.78%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Market Perform
$23
Feb-20-24 Downgrade
HSBC Securities
Hold → Reduce
Jan-03-24 Initiated
Barclays
Underweight
$21
Dec-22-23 Initiated
HSBC Securities
Hold
$27
Oct-23-23 Upgrade
JP Morgan
Neutral → Overweight
$27 → $30
Jul-03-23 Reiterated
Morgan Stanley
Underweight
$37 → $27
Jun-28-23 Downgrade
Deutsche Bank
Buy → Hold
$46 → $34
Feb-23-23 Initiated
Loop Capital
Buy
$45
Nov-23-22 Resumed
Morgan Stanley
Underweight
$39
Nov-22-22 Upgrade
Cowen
Market Perform → Outperform
$43 → $54
Nov-18-22 Upgrade
JP Morgan
Neutral → Overweight
$42
Nov-11-22 Upgrade
Deutsche Bank
Hold → Buy
Apr-01-22 Downgrade
Robert W. Baird
Outperform → Neutral
$70 → $51
Dec-16-21 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$56 → $49
Mar-25-21 Reiterated
Deutsche Bank
Hold
$49 → $55
Jan-11-21 Upgrade
Robert W. Baird
Neutral → Outperform
$55
Jan-11-21 Upgrade
Guggenheim
Neutral → Buy
$55
Jan-08-21 Resumed
Credit Suisse
Neutral
$42
Apr-06-20 Upgrade
UBS
Sell → Neutral
$49 → $44
Apr-03-20 Upgrade
Deutsche Bank
Sell → Hold
$51 → $43
Show Previous Ratings
Dec-13-24 05:55PM
(The Wall Street Journal) +6.78%
05:15PM
12:50PM
11:44AM
09:00AM
05:00AM
Loading…
05:00AM
Dec-12-24 05:50PM
09:00AM
07:16AM
05:00AM
Dec-11-24 05:38PM
05:12PM
04:20PM
04:16PM
04:10PM
02:28PM
Loading…
02:28PM
02:23PM
(The Wall Street Journal)
01:12PM
08:27AM
05:50AM
Dec-10-24 05:35PM
05:00PM
04:33PM
03:58PM
03:51PM
03:51PM
03:38PM
03:37PM
03:04PM
02:50PM
02:40PM
Loading…
02:40PM
02:30PM
02:16PM
02:08PM
02:05PM
01:49PM
01:29PM
01:29PM
12:58PM
12:51PM
10:00AM
Dec-09-24 04:55PM
Dec-08-24 09:00AM
Dec-06-24 05:45PM
09:00AM
Dec-05-24 06:45AM
Dec-02-24 03:53AM
Nov-29-24 05:45PM
04:30PM
11:15AM
06:48AM
Nov-26-24 08:30AM
04:21AM
Nov-25-24 03:46PM
(The Wall Street Journal)
12:24PM
Nov-23-24 05:30AM
(The Wall Street Journal)
Nov-22-24 04:10AM
02:35AM
Nov-21-24 03:59PM
Nov-20-24 05:45PM
Nov-14-24 11:30AM
Nov-13-24 05:45PM
08:10AM
Nov-07-24 08:30AM
01:00AM
(Thomson Reuters StreetEvents)
Nov-06-24 04:00PM
03:50AM
(Thomson Reuters StreetEvents)
02:23AM
Nov-05-24 07:29AM
05:40AM
Nov-04-24 03:11PM
Nov-03-24 11:25AM
Oct-31-24 09:00AM
06:40AM
06:14AM
Oct-30-24 01:58PM
09:00AM
Oct-29-24 12:09PM
11:44AM
10:00AM
09:00AM
Oct-28-24 11:05AM
Oct-25-24 07:28AM
04:13AM
Oct-24-24 04:47PM
08:20AM
08:00AM
06:06AM
04:00AM
03:05AM
(Thomson Reuters StreetEvents)
Oct-23-24 08:13PM
03:09AM
Oct-22-24 08:49PM
(Supermarket News) -6.89%
05:31PM
05:22PM
04:40PM
04:04PM
02:56PM
12:41PM
12:31PM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. 10% Owner Sep 11 '24 Sale 11.13 11,619,998 129,330,578 23,239,996 Sep 13 07:04 PM Walgreens Boots Alliance, Inc. 10% Owner Aug 01 '24 Sale 240.56 4,438,171 1,067,646,416 19,980,000 Aug 05 06:44 PM Walgreens Boots Alliance Holdi Affiliate Aug 01 '24 Proposed Sale 244.46 3,398,929 830,902,183 Aug 01 08:56 PM Walgreens Boots Alliance, Inc. 10% Owner May 22 '24 Sale 215.12 1,859,390 400,000,158 24,418,171 May 24 04:05 PM Bhandari Inderpal S Director Apr 11 '24 Buy 18.05 3,000 54,150 3,000 Apr 15 05:45 PM Mahajan Manmohan EVP and Global CFO Apr 02 '24 Buy 19.38 6,000 116,280 166,969 Apr 02 06:40 PM Walgreens Boots Alliance, Inc. 10% Owner Feb 07 '24 Sale 235.41 4,212,395 991,639,907 26,277,561 Feb 09 07:00 AM JARRETT VALERIE B Director Jan 29 '24 Buy 22.44 4,456 99,993 4,456 Jan 31 04:11 PM SCHLICHTING NANCY M Director Jan 16 '24 Sale 23.05 15,209 350,567 0 Jan 18 04:18 PM WENTWORTH TIMOTHY C Chief Executive Officer Jan 05 '24 Buy 24.22 10,000 242,220 585,122 Jan 08 07:29 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite